Frontlight ResearchEarly access
Atopic dermatitis (eczema) trials in France
11 of 20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Where
- Lille, Paris, Rouen Cedex, Toulouse
- Age
- 18 years to 64 years
- People
- 165 worldwide
- Run by
- Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00 - Phase 2Taking peopleA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Where
- Martigues
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Apogee Therapeutics, Inc.
See details and how to joinNCT07003425 - Phase 3Not yet taking people in FranceA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Nantes, Romans-Sur-Isere, Toulouse Cedex 9
- Age
- 6 months to 18 years
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - Phase 3Not yet taking people in FranceA Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
- Where
- Bordeaux, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Le Mans Cedex 9, Lille Cedex, Nantes, Niort, Paris, Paris Cedex 18, Pierre-Bénite, Poitiers, Rennes, Rouen Cedex, Saint-Priest-en-Jarez, Toulon Cedex 9
- Age
- 12 years and over
- People
- 230 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00 - Phase 2Taking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Brest, Lille, Lorient, Nantes, Nice, Paris, Pierre-Bénite, Reims, Rouen Cedex
- Age
- 18 years to 100 years
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - No phaseTaking peopleDouble-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults
- Where
- Caen
- People
- 86
- Run by
- University Hospital, Caen
See details and how to joinNCT07358000 - Phase 1Not yet taking people in FranceA Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
- Where
- Marseille
- Age
- 18 years to 64 years
- People
- 291 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 - Phase 2Not yet taking people in FranceA Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
- Where
- Martigues
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- Apogee Therapeutics Inc.
See details and how to join2024-519795-11-00 - No phaseTaking peopleEffect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
- Where
- Amiens, Caen, Grenoble, Lyon, Rouen, Tours
- Age
- 1 day to 14 days
- People
- 400 worldwide
- Run by
- Société des Produits Nestlé (SPN)
See details and how to joinNCT06943469 - No phaseTaking peopleDeployment o the Multidisciplinary Prospective Cohort Imminent
- Where
- Lille
- Age
- 18 years and over
- People
- 2,200
- Run by
- University Hospital, Lille
See details and how to joinNCT04334031 - Phase 3CompletedEfficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
- Where
- Bordeaux, Pierre-Bénite
- Age
- 18 years and over
- People
- 277 worldwide
- Run by
- medac GmbH
See details and how to joinNCT06239311 · EU 2023-504443-13-00